Trial Profile
A Phase I, Open-Label, 2-Part Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism and Excretion of DA-1229 in Healthy Male Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2014
Price :
$35
*
At a glance
- Drugs Evogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Dong-A ST
- 24 Oct 2014 New trial record